Papers - KATSUNO, Masahisa
-
Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Reviewed
Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, Yamamoto M, Mukai E, Nakamura T, Katsuno M, Hattori N, Sobue G.
J Neurol Sci. Vol. 287 page： 178-184 2009
-
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Reviewed
Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, Sobue G, Taylor JP, Sumner CJ, Fischbeck KH, Pennuto M.
Neuron Vol. 63 page： 316-328 2009
-
TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases. Reviewed
Iguchi Y, Katsuno M, Niwa J, Yamada S, Sone J, Waza M, Adachi H, Tanaka F, Nagata K, Arimura N, Watanabe T, Kaibuchi K, Sobue G.
J Biol Chem. Vol. 284 page： 2059-22066 2009
-
Getting a handle on Huntington's disease: the case for cholesterol. Invited
Katsuno M*, Adachi H, Sobue G.
Nat Med. Vol. 15 page： 253-254 2009
-
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Reviewed
Banno H, Katsuno M*, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G.
Ann Neurol. Vol. 65 page： 140-150 2009
-
B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist. Reviewed
Watanabe H, Hirayama M, Noda A, Ito M, Atsuta N, Senda J, Kaga T, Yamada A, Katsuno M, Niwa T, Tanaka F, Sobue G.
Neurology Vol. 72 page： 621-626 2009
-
Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imaging. Reviewed
Senda J, Ito M, Watanabe H, Atsuta N, Kawai Y, Katsuno M, Tanaka F, Naganawa S, Fukatsu H, Sobue G.
Amyotroph Lateral Scler. Vol. 29 page： 1-8 2009
-
Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. Invited
Banno H, Katsuno M*, Suzuki K, Tanaka F. Sobue G.
Vol. 10 page： 1000-1012 2009
-
Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). Invited
Suzuki K, Katsuno M, Banno H, Sobue G.
Neuropathology Vol. 29 page： 509-516 2009
-
Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. Reviewed
Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G.
J Neurol Sci. Vol. 279 page： 57-61 2009
-
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Reviewed
Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, *Sobue G.
Ann Neurol. Vol. 65 page： 140-150 2009
-
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Reviewed
Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, Sobue G, Taylor JP, Sumner CJ, Fischbeck KH, Pennuto M.
Neuron Vol. 63 page： 316-328 2009
-
TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases. Reviewed
Iguchi Y, Katsuno M, Niwa J, Yamada S, Sone J, Waza M, Adachi H, Tanaka F, Nagata K, Arimura N, Watanabe T, Kaibuchi K, Sobue G.
J Biol Chem. Vol. 284 page： 22059-22066 2009
-
Getting a handle on Huntington's disease: the case for cholesterol. Invited Reviewed
Katsuno M, Adachi H, *Sobue G.
Nat Med. Vol. 15 page： 253-254 2009
-
Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Reviewed
Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G.
muscle Nerve Vol. 38 ( 2 ) page： 964-971 2008.8
-
Cognitive impairment in spinocerebellar ataxia type 6. Reviewed
Suenaga M, Kawai Y, Watanabe H, Atsuta N, Ito M, Tanaka F, Katsuno M, Fukatsu H, Naganawa S, Sobue G.
J Neurol Neurosurg Psychiatry Vol. 79 page： 496-499 2008
-
Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population Reviewed
Iijima M, Koike H, Hattori N, Tamakoshi A, Katsuno M, Tanaka F, Yamamoto M, Arimura K, Sobue G.
J Neurol Neurosurg Psychiatry Vol. 79 page： 1040-1043 2008
-
Molecular Genetics and Biomarkers of Polyglutamine Diseases. Reviewed
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Adachi H, Tanaka F, Sobue G
Current Mol Med Vol. 8 page： 221-234 2008
-
Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Reviewed
Takeuchi Y, Katsuno M*, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G.
Muscle Nerve Vol. 38 page： 964-971 2008
-
Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Invited Reviewed
Adachi H, Waza M, Katsuno M, Tanaka F, Doyu M, Sobue G. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Neuropathol Appl Neurobiol Vol. 33 ( 2 ) page： 135-151 2007